Delivery Order SPE2DB22D3301-SPE2DB25FX4FZ

Award Date 10/23/24
Potential Completion Date 10/24/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of VIVITROL 380 MG VIAL-DILUENTS. The firm-fixed-price delivery order, valued at $7,314.48, has an ultimate completion date of October 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, involves the delivery of VIVITROL 380 MG VIAL-DILUENTS to support the U.S. government's medical and healthcare needs. The $12,599.09 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 30, 2024. The contract does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) involves the delivery of Vivitrol 380 mg vials and diluents. The $16,578.92 firm fixed-price delivery order contract has a period of performance through June 17, 2025. Amerisourcebergen Drug Corp is an established pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,904.41 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,708.67, is for the delivery of Vivitrol 380 mg vials and diluents. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of August 9, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.06 firm-fixed-price delivery order is for the supply of 380 mg VIVITROL vials and diluents. The award has a completion date of May 14, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,208.52, is a firm fixed-price delivery order for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $15,018.36 and is a firm-fixed-price delivery order with a completion date of May 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $7,242.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Vivitrol 380 mg vial-diluents. The contract is a delivery order, with a firm fixed price pricing type, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4FZ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $15,515.70 firm fixed price contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialty medication. The award has no set-aside designation, indicating open competition. This DLA IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceuticals and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 1/22/25, 9:19 AM